105 related articles for article (PubMed ID: 21996955)
41. [Japanese nationwide post-marketing survey of S-1 in patients with advanced gastric cancer].
Ohtsu A
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():52-6. PubMed ID: 16897972
[TBL] [Abstract][Full Text] [Related]
42. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
43. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
44. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and feasibility of combination chemotherapy with S-1 and cisplatin (2 weeks regimen) for advanced gastric cancer.
Abe S; Tsuji Y; Tsushima T; Kogawa T; Abe M; Onodera Y; Mizushima T; Kukitsu T; Sumiyoshi T; Yoshizaki N; Ishii T; Kondo H
Jpn J Clin Oncol; 2010 Apr; 40(4):302-6. PubMed ID: 20089529
[TBL] [Abstract][Full Text] [Related]
46. [A case of advanced gastric cancer treated with S-1 and S-1/paclitaxel showing complete response twice].
Matsuyama J; Naitou A; Hiraki M; Matsumoto S; Hashimoto K; Yokoyama S; Morita S; Morimoto T; Fukushima Y; Nishishou I; Nomura T; Sasaki Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2297-9. PubMed ID: 20037401
[TBL] [Abstract][Full Text] [Related]
47. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
[TBL] [Abstract][Full Text] [Related]
48. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
[TBL] [Abstract][Full Text] [Related]
49. A late phase II study of S-1 for metastatic pancreatic cancer.
Okusaka T; Funakoshi A; Furuse J; Boku N; Yamao K; Ohkawa S; Saito H
Cancer Chemother Pharmacol; 2008 Apr; 61(4):615-21. PubMed ID: 17520253
[TBL] [Abstract][Full Text] [Related]
50. S-1 monotherapy in patients with advanced biliary tract cancer.
Sasaki T; Isayama H; Yashima Y; Yagioka H; Kogure H; Arizumi T; Togawa O; Matsubara S; Ito Y; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tada M; Kawabe T; Omata M
Oncology; 2009; 77(1):71-4. PubMed ID: 19556812
[TBL] [Abstract][Full Text] [Related]
51. [A case of unresectable gastric cancer with poor ingestion].
Shinohara T; Hashimoto T; Naito M; Matsumoto H; Kuramochi H; Nakagawa M; Ishii F; Yamashita Y
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1503-6. PubMed ID: 24231703
[TBL] [Abstract][Full Text] [Related]
52. [S-1-based chemotherapy for unresectable advanced gastric cancer of the elderly or patients with renal dysfunction].
Fujiya K; Akiyama J; Yokota E; Asayama N; Ogami T; Nakajima R; Nishimura S; Sakurai T; Nagata N; Yokoi C; Kojima Y; Kobayakawa M; Gotoda T; Shimbo T; Uemura N
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1817-20. PubMed ID: 22083189
[TBL] [Abstract][Full Text] [Related]
53. S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer.
Yamamoto M; Sakaguchi Y; Kinjo N; Yamaguchi S; Egashira A; Minami K; Ikeda Y; Morita M; Toh Y; Okamura T
Ann Surg Oncol; 2016 Feb; 23(2):546-51. PubMed ID: 26442923
[TBL] [Abstract][Full Text] [Related]
54. Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapy.
Yonemori K; Shimada Y; Goto A; Ura T; Arai T; Hamaguchi T; Muro K; Yamada Y; Shirao K
Gastric Cancer; 2004; 7(4):204-10. PubMed ID: 15616768
[TBL] [Abstract][Full Text] [Related]
55. The effect of lentinan combination therapy for unresectable advanced gastric cancer.
Higashi D; Seki K; Ishibashi Y; Egawa Y; Koga M; Sasaki T; Hirano K; Mikami K; Futami K; Maekawa T; Sudo M
Anticancer Res; 2012 Jun; 32(6):2365-8. PubMed ID: 22641676
[TBL] [Abstract][Full Text] [Related]
56. [Postoperative adjuvant chemotherapy for gastric cancer after the adjuvant chemotherapy trial of S-1 for gastric cancer in Hiroshima prefecture: results from a questionnaire survey and future challenges].
Yamaguchi K; Hirabayashi N; Ninomiya M; Shinozaki K; Hatanaka N; Matsuda H; Tanabe K
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2555-9. PubMed ID: 24335369
[TBL] [Abstract][Full Text] [Related]
57. [Clinical Impact of adjuvant chemotherapy in patients with T1N2/3 Gastric cancer].
Tsuchida K; Kunisaki C; Watanabe T; Ono H; Oshima T; Fukushima T; Yoshikawa T; Rino Y; Imada T; Masuda M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2239-41. PubMed ID: 25731482
[TBL] [Abstract][Full Text] [Related]
58. [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
Nakamura M; Koga M; Aoki M; Iwamoto O; Koga C; Kusukawa J
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1841-3. PubMed ID: 22083193
[TBL] [Abstract][Full Text] [Related]
59. [Clinical significance of the human epidermal growth factor receptor 2( HER2) in patients with recurrent gastric cancer who received S-1 adjuvant chemotherapy].
Aoyama T; Hayashi T; Fujikawa H; Ogata T; Cho H; Wada H; Kitani Y; Yukawa N; Oshima T; Rino Y; Ozawa Y; Masuda M; Yoshikawa T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1647-9. PubMed ID: 24393876
[TBL] [Abstract][Full Text] [Related]
60. Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.
Jeong JH; Park SR; Ahn Y; Ryu MH; Ryoo BY; Kong SY; Yook JH; Yoo MW; Kim BS; Kim BS; Kang YK
Gastric Cancer; 2017 Jan; 20(1):146-155. PubMed ID: 26715117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
